Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 12/2019

25.05.2019 | Original Paper

Trends in psychiatric disorders prevalence and prescription patterns of children in Alberta, Canada

verfasst von: Brenda M Y Leung, Peter Kellett, Erik Youngson, Josh Hathaway, Maria Santana

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe the trends in the prevalence and incidence of children with psychiatric disorders, the types of medication prescribed, and the type of physician providing the prescriptions.

Method

This retrospective study linked six population-based administrative databases (2008–2015) in Alberta, Canada.

Results

The prevalence of paediatric psychiatric disorders increased from 12.6 per 100 population in 2008 to 15.0 per 100 population in 2015, while the incidence rate increased from 2.0 per 100 population to 2.2 per 100 population in the same period. The proportion of patients dispensed any psychiatric medication increased from 21.4% in 2008 to 28.2% in 2015. Over the same period, dispensations for antidepressants increased from 7.0% to 11.2% and stimulants to treat ADHD, from 11.9% to 15.9%. For antidepressants, general practitioners (GPs) wrote the highest proportion of prescriptions (44.3% in 2011–48.1% in 2015), while paediatricians wrote the lowest proportion (8.7% in 2011–11.0% in 2015) and the proportion by psychiatrists decreased from 33.4% in 2011 to 27.2% in 2015. For stimulants to treat ADHD, paediatricians were the most frequent prescribers (36.9% in 2011–39.3% in 2015) followed by GPs as the second most frequent (33.1% in 2011–33.5% in 2015), while psychiatrists were the least likely to prescribe stimulants for ADHD.

Conclusion

The increasing trend of psychiatric diagnoses and medication prescriptions in the paediatric population is evident using population-based administrative databases. The lack of safety and adverse consequences of medication use in this cohort warrants additional monitoring data.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chafe R, Audas R (2014) The unseen high-cost users: children and youth with mental illness. HealthcarePapers 14(2):52–56CrossRef Chafe R, Audas R (2014) The unseen high-cost users: children and youth with mental illness. HealthcarePapers 14(2):52–56CrossRef
2.
Zurück zum Zitat Merikangas KR, Nakamura EF, Kessler RC (2009) Epidemiology of mental disorders in children and adolescents. Dial Clin Neurosci 11(1):7–20 Merikangas KR, Nakamura EF, Kessler RC (2009) Epidemiology of mental disorders in children and adolescents. Dial Clin Neurosci 11(1):7–20
4.
Zurück zum Zitat Waddell C, Shepherd C, Schwartz C, Barican J (2014) Child and youth mental disorders: prevalence and evidence-based interventions: a research report for the British Columbia ministry of children and family development. Simon Fraser University, Children’s Health Policy Centre Waddell C, Shepherd C, Schwartz C, Barican J (2014) Child and youth mental disorders: prevalence and evidence-based interventions: a research report for the British Columbia ministry of children and family development. Simon Fraser University, Children’s Health Policy Centre
9.
Zurück zum Zitat Brault MC, Lacourse E (2012) Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007. Can J Psychiatry 57(2):93–101CrossRef Brault MC, Lacourse E (2012) Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007. Can J Psychiatry 57(2):93–101CrossRef
14.
Zurück zum Zitat Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J (2008) Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Can Med Assoc J 178(8):1005CrossRef Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J (2008) Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Can Med Assoc J 178(8):1005CrossRef
17.
Zurück zum Zitat Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P (2016) Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England) 388(10047):881–890. https://doi.org/10.1016/S0140-6736(16)30385-3 CrossRef Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P (2016) Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England) 388(10047):881–890. https://​doi.​org/​10.​1016/​S0140-6736(16)30385-3 CrossRef
Metadaten
Titel
Trends in psychiatric disorders prevalence and prescription patterns of children in Alberta, Canada
verfasst von
Brenda M Y Leung
Peter Kellett
Erik Youngson
Josh Hathaway
Maria Santana
Publikationsdatum
25.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 12/2019
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-019-01714-w

Weitere Artikel der Ausgabe 12/2019

Social Psychiatry and Psychiatric Epidemiology 12/2019 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.